Bay Colony Advisory Group Inc d b a Bay Colony Advisors Has $2.63 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Bay Colony Advisory Group Inc d b a Bay Colony Advisors lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 5,192 shares of the healthcare conglomerate’s stock after selling 280 shares during the quarter. Bay Colony Advisory Group Inc d b a Bay Colony Advisors’ holdings in UnitedHealth Group were worth $2,626,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. Strategic Family Wealth Counselors L.L.C. grew its stake in UnitedHealth Group by 17.4% in the fourth quarter. Strategic Family Wealth Counselors L.L.C. now owns 1,339 shares of the healthcare conglomerate’s stock valued at $678,000 after purchasing an additional 198 shares in the last quarter. Callan Family Office LLC boosted its stake in shares of UnitedHealth Group by 822.9% during the 4th quarter. Callan Family Office LLC now owns 31,361 shares of the healthcare conglomerate’s stock worth $15,864,000 after acquiring an additional 27,963 shares in the last quarter. Chatham Capital Group Inc. boosted its stake in shares of UnitedHealth Group by 0.5% during the 4th quarter. Chatham Capital Group Inc. now owns 11,262 shares of the healthcare conglomerate’s stock worth $5,697,000 after acquiring an additional 60 shares in the last quarter. Welch & Forbes LLC boosted its stake in shares of UnitedHealth Group by 5.6% during the 4th quarter. Welch & Forbes LLC now owns 5,322 shares of the healthcare conglomerate’s stock worth $2,692,000 after acquiring an additional 284 shares in the last quarter. Finally, E Fund Management Co. Ltd. boosted its stake in shares of UnitedHealth Group by 56.6% during the 4th quarter. E Fund Management Co. Ltd. now owns 10,634 shares of the healthcare conglomerate’s stock worth $5,379,000 after acquiring an additional 3,843 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of several recent analyst reports. Piper Sandler decreased their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial decreased their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft increased their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Trading Up 2.5 %

Shares of UNH opened at $487.76 on Friday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a 50 day simple moving average of $514.11 and a 200-day simple moving average of $554.35. The stock has a market cap of $448.87 billion, a PE ratio of 31.47, a PEG ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $5.83 EPS. On average, sell-side analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.72%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.